Breaking News

Can Google and Microsoft help hospitals fight cyberattacks?

June 13, 2024
Health Tech Correspondent

Good morning health tech readers!

I love it here at STAT, but I still get a perverse thrill from the idea that AI might steal my job, no matter how unlikely that possibility. Oh, to be rendered obsolete! I shall now wallow in temporary misery before I rise up to fight the machines. It's like a movie! Nevertheless, I was more alarmed than excited by the idea that AI might falsely accuse me of using AI to do my job? And that this would be how I lost my job to AI? Unacceptable. To be absolutely clear, and to steal a joke from the story I just linked to: The newsletter that follows was written entirely by a human writer.

Reach the human: mario.aguilar@statnews.com

Cybersecurity

Will security training from Google and Microsoft help prevent hospital cyberattacks?

Google and Microsoft this week offered training and software discounts to help rural hospitals secure their data from the constant onslaught of ransomware attacks and other data breaches. 

But as information security experts and researchers told STAT's Casey Ross and Mohana Ravindranath, the effort falls far short of what needs to be done to prevent what seem to be a never-ending cascade of cyberattacks. It's a life or death problem and most rural hospitals don't have enough money, or staff, to tackle it. Some free tools from big tech is unlikely likely to solve the problem.

An effort that's more likely to create impact are federally dictated health care-specific performance goals for cybersecurity that at least give hospitals a target to strive for. One expert suggested that vendors could band together in an effort to help rural heath centers meet these goals.

Read more about the challenges and possible solutions here


REsearch

Now there's a ChatGPT-like model for pathology slides

In a new Nature paper, researchers describe a new AI model that can ingest pathology images, converse with a clinician about a slide, take in additional information about the case, or produce a pathology report draft. Called PathChat, the model was designed by researchers at Mass General Brigham and other institutes.

In benchmark tests, PathChat outperformed existing AI models on several tasks related to describing and interpreting images. In the future, researcher Faisal Mahmood suggested a Food and Drug Administration regulated version could help triage cases and suggest to human pathologists where they ought to focus their attention.

Read more on PathChat's development and abilities here


Telehealth

Where is telehealth, four years later?

Figure 1.2_06.09.24

Long-time readers of STAT Health Tech know we love a good visualization of telehealth use, and today's chart, from Trilliant Health, comes at symbolic moment for virtual care: It includes data through the end of the third quarter of 2023,  four years after the onset of  pandemic drove millions of new users to try new ways of talking to a doctor. It also follows Teladoc embarking on a fresh course under new CEO Chuck Divita, and a bit more than a month after Optum and Walmart moved to shutter their virtual care businesses.

So what do we learn? A continuation of what we knew: Telehealth use is higher than where it was before the pandemic but lower than the 2020 peak — and much lower than where many analysts, investors, and entrepreneurs thought it would end up.

"Telehealth utilization trends signal that patients do not view telehealth as a substitute for in-person care for most conditions, except for behavioral health," wrote Trilliant chief research officer Sanjula Jain, adding: "Because it is now clear that the pandemic-era telehealth market predictions were ultimately misguided, stakeholders across the health economy must reevaluate their approach to telehealth." Read her whole post here.



Wearables

Verily will pivot again, and lean into GLP-1s

The company that can't stop pivoting, pivots again: Alphabet life science subsidiary Verily earlier this week announced it would launch a new chronic disease management solution, called Lightpath. The company says Lightpath is an "evolved" version of its existing chronic disease offering Onduo.

Set to launch in 2026, the first offering, Lightpath Metabolic will, like Onduo, include programs for people with type 1 and type 2 diabetes and hypertension. And, it will also offer prescriptions for GLP-1 medications and a program for weight loss. In keeping with Verily's current strategy around precision health, the company's new chief product officer Myoung Cha told STAT's Brittany Trang that Lightpath would use artificial intelligence and data from devices like CGMs to personalize treatment to individuals.

Read more about Verily's plans for Lightpath here


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months, npj Parkinson's Disease
  • Medical-targeted ransomware is breaking records after Change Healthcare's $22M payout, Wired
  • With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy, STAT

Thanks for reading! More on Tuesday - Mario

Mario Aguilar covers how technology is transforming health care. He is based in New York.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments